LILIA AI, INC. — SEC Form D Filing

LILIA AI, INC. filed an SEC Form D on March 12, 2026, reporting $2.00M raised in Health Technology.

Form D filing details

Filing
SEC Form D
Filing date
March 12, 2026
Amount reported
$2.00M
Round stage
Seed
Industry
Health Technology
Website
https://www.lilia-ai.com/

What the company does

Securities: Debt. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Lilia AI addresses the challenge of accurately detecting brain aneurysms, which can lead to life-threatening conditions if not identified in time.

Solution

The company utilizes advanced AI technologies to analyze cranial CT angiograms quickly and accurately, enabling timely diagnoses for medical professionals.

Why now

With increasing awareness and prevalence of brain aneurysms, there is a pressing need for innovative diagnostic solutions that can improve patient outcomes.

Verdict

Investors said yes to LILIA AI because the narrative around AI-driven diagnostics in healthcare is compelling, especially with the urgency surrounding brain aneurysm detection. They implicitly bet on the belief that AI can consistently outperform traditional methods, recognizing both its transformative potential and its current limitations in accuracy. This cleared because the immediacy of the healthcare need was evident, not because the competition in healthcare AI is weak.

Source: SEC EDGAR Form D filing